Anticoagulation in extracorporeal circulation using recombinant hirudin: a case report

Beholz, S.; Grubitzsch, H.; Bergmann, B.; Wollert, H-G.; Eckel, L.
June 2000
Perfusion;Jun2000, Vol. 15 Issue 3, p257
Academic Journal
Heparin-induced thrombocytopenia (HIT) is a severe complication following the application of heparin; antibodies against complexes of heparin and PDF4 initiate activation of platelets. This may lead to massive thrombembolism, which is associated with a slight and transient drop of platelets in HIT I or a drop below 50% after approximately 5 days in HIT II. Further administration of heparin has to be strictly avoided in these patients. Immunologic evidence for HIT can easily be obtained by the heparin-induced platelet aggregation assay. If anticoagulation is necessary, different, alternative drugs are available. Recombinant hirudin (r-hirudin) is a well-established drug for safe anticoagulation. Monitoring is possible by estimating the plasma level of r-hirudin from the ecarin-clotting time. We report a case of a patient with prosthetic aortic valve endocarditis and HIT II who suffered from massive postoperative bleeding requiring massive substitution of blood components and coagulants caused by free circulating r-hirudin due to the use of a hemofilter.


Related Articles

  • Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin allergy. Pappalardo, F.; Franco, A.; G., G. Crescenzi; Poli, A.; Zangrillo, A.; Koster, A. // Perfusion;Jan2007, Vol. 22 Issue 1, p67 

    Heparin-induced IgE-mediated hypersensitivity and anaphylactoid reactions, although rare, can pose a serious clinical problem for patients requiring cardiopulmonary bypass (CPB). Bivalirudin is a bivalent reversible direct thrombin inhibitor, with a half-life of 25 min, eliminated mostly by...

  • Education in Heart: Triple antithrombotic management after stent implantation: when and how? Schömig, Albert; Sarafoff, Nikolaus; Seyfarth, Melchior // Heart;Aug2009, Vol. 95 Issue 15, p12 

    The article offers information on the effectiveness of dual antiplatelet therapy (DAT) and oral anticoagulation (OAC) in the prevention of various thromboembolic events. It relates that OAC has been proven to be effective for patients at risk of thromboembolic events caused by mechanical heart...

  • Enoxaparin sodium/heparin.  // Reactions Weekly;6/25/2011, Issue 1357, p14 

    The article describes the case of a 24-year-old pregnant woman who presented with heparin-induced thrombocytopenia (HIT) during anticoagulant therapy with unfractionated heparin and enoxaparin sodium, published in the May 2011 issue of the journal "Medical Science Monitor."

  • Deleterious effects of oxygen during extracorporeal circulation for the microcirculation in vivo Kamler, M.; Wendt, D.; Pizanis, N.; Milekhin, V.; Schade, U.; Jakob, H. // European Journal of Cardio-Thoracic Surgery;Sep2004, Vol. 26 Issue 3, p564 

    Objective: Clinical complications arising from extracorporeal circulation (ECC) have been linked to disturbances in the microcirculation. Hyperoxia, a mainstay of supportive treatment, is clinically used for a variety of pathological states. In previous in vivo animal experiments we found...

  • Heparinless cardiopulmonary bypass with argatroban in dogs Rikitake, Kazuhisa; Okazaki, Yukio; Naito, Kozo; Ohtsubo, Satoshi; Natsuaki, Masafumi; Itoh, Tsuyoshi // European Journal of Cardio-Thoracic Surgery;May2004, Vol. 25 Issue 5, p819 

    Objectives: Systemic heparinization is usually required for cardiopulmonary bypass (CPB). However, problems such as heparin-induced thrombocytopenia, protamine shock, and antithrombin III deficiency exist related to CPB with heparinization. The aim of this study was to evaluate argatroban (ARG)...

  • R-Hirudin as Anticoagulant in Regular Hemodialysis Therapy: Finding of Therapeutic R-Hirudin Blood/Plasma Concentrations and Respective Dosages. Bucha, Elke; Nowak, Goetz; Czerwinski, Ralf; Thieler, Heinrich // Clinical & Applied Thrombosis/Hemostasis;Jul1999, Vol. 5 Issue 3, p164 

    Recently heparin-induced thrombocytopenia type II has been diagnosed more frequently and does not exclude hemodialysis patients. Up to now, recombinant hirudin is the only available anticoagulant showing no immunologic cross reactions with heparin. However, the use of r-hirudin in hemodialysis...

  • Heparin-Induced Thrombocytopenia. Cooney, Maureen F. // Critical Care Nurse;Dec2006, Vol. 26 Issue 6, p30 

    The article presents a study about a complication called heparin-induced thrombocytopenia (HIT). It discusses the proper diagnosis and management of HIT patients and its consequences. HIT is caused by exposure to heparin in hospitals and may cause diseases, like HIT thrombotic syndrome, and...

  • Simple and Safe Method to Prepare Patients With Prosthetic Heart Valves for Surgical Dental Procedures. Russo, Giulia; Dal Corso, Lorenza; Biasiolo, Alessandra; Berengo, Mario; Pengo, Vittorio // Clinical & Applied Thrombosis/Hemostasis;Apr2000, Vol. 6 Issue 2, p90 

    Temporary discontinuation of high-intensity oral anticoagulant treatment is not recommended in patients undergoing dental surgery. This policy is not based on solid data from randomized clinical trials but on expert consensus. The alternative, i.e., to continue treatment and treat patients with...

  • Drying properties of bloodstains on common indoor surfaces. Ramsthaler, Frank; Schmidt, Peter; Bux, Roman; Potente, Stefan; Kaiser, Cristina; Kettner, Mattias // International Journal of Legal Medicine;Sep2012, Vol. 126 Issue 5, p739 

    When blood reaches an extracorporeal surface, a drying process is initiated. Properties of this drying process may be crucial for the correct assessment of case-specific time lapses, however, there is a lack of systematic studies concerning the drying times of blood. We present a study on drying...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics